Orthocell Demonstrates Real-World Utility of Remplir in Conflict Setting
Orthocell Limited (ASX: OCC) has reported the successful use of its Remplir™ nerve repair device in 23 surgical procedures involving injured soldiers in Ukraine, highlighting its practical application in high-intensity medical environments.
The device, which is designed to support the repair and protection of damaged nerves, has been deployed in both initial and follow-up surgical treatments. Feedback from surgeons has been encouraging, with clinicians noting its effectiveness in nerve repair procedures after receiving remote training from specialist advisors.
This real-world usage underscores the product’s adaptability in demanding conditions. Its long shelf life, ability to be stored at room temperature, and ease of transport make it particularly suitable for use in military and emergency settings where logistical constraints are critical.
The development also opens up broader opportunities for Orthocell to engage with defence and emergency healthcare networks globally, as the company continues to evaluate potential expansion into similar use cases.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Orthocell Demonstrates Real-World Utility of Remplir in Conflict Setting
Orthocell Limited (ASX: OCC) has reported the successful use of its Remplir™ nerve repair device in 23 surgical procedures involving injured soldiers in Ukraine, highlighting its practical application in high-intensity medical environments.
The device, which is designed to support the repair and protection of damaged nerves, has been deployed in both initial and follow-up surgical treatments. Feedback from surgeons has been encouraging, with clinicians noting its effectiveness in nerve repair procedures after receiving remote training from specialist advisors.
This real-world usage underscores the product’s adaptability in demanding conditions. Its long shelf life, ability to be stored at room temperature, and ease of transport make it particularly suitable for use in military and emergency settings where logistical constraints are critical.
The development also opens up broader opportunities for Orthocell to engage with defence and emergency healthcare networks globally, as the company continues to evaluate potential expansion into similar use cases.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au